Login
Toggle sidebar

Lint: sarcoidosis-1

Acronyms
warning

"The World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) has also published detailed organ-specific criteria (2014) 14."

Line 29:76 · 'WASOG' has no definition. Spell it out if it's unfamiliar to the audience.

"Additionally, a positive Kveim-Siltzbach skin test may help confirm the diagnosis, although it is not in routine clinical use and is not FDA-approved 3,16. This test involves intradermal injection of sarcoid-involved splenic material; the test is considered positive when a typical sarcoid granuloma is diagnosed on histology, 4-6 weeks after infection 4,17."

Line 30:141 · 'FDA' has no definition. Spell it out if it's unfamiliar to the audience.

"It is thought to represent a disorder of immune regulation, particularly of cell-mediated immunity 3. RNA and DNA from Mycobacterium and Propionibacterium have been detected in sarcoidosis lesions, raising the possibility of an infectious trigger 4."

Line 40:117 · 'RNA' has no definition. Spell it out if it's unfamiliar to the audience.
List Caps
warning

"Schaumann bodies: laminated calcium-containing concretions"

Line 51:11 · In general, we don't start a list item with a capital letter. Exceptions are proper nouns.
EG List And
warning

"Historically, sarcoidosis was also known as Besnier-Boeck-Schaumann disease/syndrome, or various combinations thereof, e.g. Besnier-Boeck disease, Boeck disease, or Schaumann syndrome 10."

Line 87:123 · An e.g. list gives selected examples, so it should not end with 'and' or 'or': 'e.g. Besnier-Boeck disease, Boeck disease, or'.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Complications"

Line 79:1 · "Complications" is under the wrong parent heading (found under "Treatment and prognosis").
There Is
suggestion

"There is considerable regional variability, with the highest incidence in Northern European (Scandinavian) countries (15 per 100,000), followed by North America and Australia, and the lowest incidence in East Asian countries (0.5-1 per 100,000) 15. Within regions, higher incidences have been reported in Black and African populations than in White, Hispanic, or Asian populations 15."

Line 15:4 · Don't start a sentence with 'There is'.
Semicolons
suggestion

"Additionally, a positive Kveim-Siltzbach skin test may help confirm the diagnosis, although it is not in routine clinical use and is not FDA-approved 3,16. This test involves intradermal injection of sarcoid-involved splenic material; the test is considered positive when a typical sarcoid granuloma is diagnosed on histology, 4-6 weeks after infection 4,17."

Line 30:248 · Use semicolons judiciously.

"highly variable; elevated in ~55% (range 30-80%) of patients 18"

Line 61:23 · Use semicolons judiciously.

"sensitivity ~65% (range 22-86%); specificity ~75% (range 54-95%) 18"

Line 62:39 · Use semicolons judiciously.

"Otherwise, the radiographic features are organ-dependent; please see individual articles (listed above)."

Line 69:60 · Use semicolons judiciously.

"Treatment is predominantly aimed at protecting individual organ function and reducing symptom burden, with prudent use of corticosteroids and other immunosuppressive agents (e.g. methotrexate, infliximab) 12,19. Relapse within 1-2 years after treatment withdrawal is relatively common (~60%; range 20-90%) 19."

Line 71:305 · Use semicolons judiciously.

"stage I: ~75%; range 60-90%"

Line 74:21 · Use semicolons judiciously.

"stage II: ~55%; range 40-70%"

Line 75:22 · Use semicolons judiciously.

"stage III: ~15%; range 10-20%"

Line 76:23 · Use semicolons judiciously.

"Sarcoidosis is derived from the Ancient Greek terms σαρξ (sarc), meaning flesh; ειδος (eidos), meaning form; and σις (-sis), a suffix meaning a process 10,11."

Line 88:82 · Use semicolons judiciously.

"Sarcoidosis is derived from the Ancient Greek terms σαρξ (sarc), meaning flesh; ειδος (eidos), meaning form; and σις (-sis), a suffix meaning a process 10,11."

Line 88:111 · Use semicolons judiciously.